Nxera Pharma Co., Ltd. (SOLTF)

5.48 +0.57 (+11.61%) USD  |  OTCM  |  Dec 29, 16:00
More

Nxera Pharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for SOLTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Takeda Pharmaceutical Co., Ltd. Upgrade
PeptiDream Inc. Upgrade
Stemcell Holdings, Inc. --
Healios KK Upgrade
AnGes, Inc. Upgrade